Vice Chief of Medicine
Cardiology
Dr. Peter A. McCullough, MD
|
|
Give Review
Dr. Peter A. McCullough practices Cardiology. He attended University of Texas Southwestern Medical School. He received awards:"11th International Vicenza Award in Critical Care Nephrology", "Fellow", "Simon Dack Award for Scholarly Excellence by the Journal of the American College of Cardiology", "Outstanding Poster Recognition", "Innovations in Health Care Award Finalist", "Listed in Guide to America’s Top Cardiologists", "Listed in Guide to America’s Top Physicians", "America’s Registry of Outstanding Professionals", "Young Investigator Award, President’s International Awards Ceremony", "Physician’s Recognition Award in Continuing Medical Education", "Chief Medical Resident's Best Teacher Award", "Alpha Omega Alpha, National Honor Medical Society", "Alpha Lambda Delta Freshman Honorary" and "Fellow (FACC)". Doctor Peter A. McCullough, MD is a published doctor as well. He has 102 publications published. The latest was: Influence of Chronic Renal Failure on Cardiac Structure. Doctor Peter A. McCullough, MD accepts all Medicare patients.
Publications
- Atrophy of the Heart After Insertion of a Left Ventricular Assist Device and Closure of the Aortic Valve.
- Chronic anticoagulation in chronic kidney Disease.
- Peter Andrew McCullough, MD, MPH: An Interview With the Editor.
- Improving detection of cardiac surgery-associated Acute kidney injury.
- Subclinical and clinical contrast-induced Acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCI...
- Screening, Diagnosis, and Management of CAD in Asymptomatic Diabetic Patients.
- Risk Factors for Heart Failure in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl.
- Reducing contrast-induced Acute kidney injury using a regional multicenter quality improvement intervention.
- Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers.
- Management of gastrointestinal bleeding in patients anticoagulated with dabigatran compared with warfarin: a retrospective, comparative case review.
- Calling for Targeted Trials in Cardiorenal Syndromes.
- Educational programs improve the preparation for dialysis and survival of patients with chronic kidney Disease.
- Ascorbic Acid for the Prevention of Contrast-Induced Acute Kidney Injury.
- The Association between Parathyroid Hormone Levels and Hemoglobin in Diabetic and Nondiabetic Participants in the National Kidney Foundation's Kidney Early Evaluation ...
- Advances in CKD Detection and Determination of Prognosis: Executive Summary of the National Kidney Foundation-Kidney Early Evaluation Program (KEEP) 2012 Annual Data R...
- The Synergistic Relationship Between Estimated GFR and Microalbuminuria in Predicting Long-term Progression to ESRD or Death in Patients With Diabetes: Results From th...
- Association between lack of health insurance and risk of death and ESRD: results from the Kidney Early Evaluation Program (KEEP).
- No independent association of serum phosphorus with risk for death or progression to end-stage renal Disease in a large screen for chronic kidney Disease.
- Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP).
- Association of Race and Body Mass Index With ESRD and Mortality in CKD Stages 3-4: Results From the Kidney Early Evaluation Program (KEEP).
- Central versus local adjudication of Myocardial infarction in a cardiac biomarker trial.
- Discovery and validation of cell cycle arrest biomarkers in human Acute kidney injury.
- The association of parathyroid hormone with ESRD and pre-ESRD mortality in the Kidney Early Evaluation Program.
- Fibrates and cardiorenal outcomes.
- Theophylline or aminophylline for the prevention of contrast-induced Acute kidney injury.
- Phidippides Cardiomyopathy: A Review and Case Illustration.
- Lipoprotein subfractions and particle size in end-stage renal Disease.
- Minimizing the renal toxicity of iodinated contrast.
- Relation Among Body Mass Index, Exercise Training, and Outcomes in Chronic Systolic Heart Failure.
- What is the Ideal Blood Pressure Goal for Patients with Stage III or Higher Chronic Kidney Disease?
- Impact of obesity on cardiovascular Disease.
- Lower Than Predicted Resting Metabolic Rate Is Associated With Severely Impaired Cardiorespiratory Fitness in Obese Individuals.
- Cardiovascular Disease in chronic kidney Disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).
- Validity of Estimated Glomerular Filtration Rates for Assessment of Baseline and Serial Renal Function in Patients With Atherosclerotic Renal Artery Stenosis: Implicat...
- Identification and management of chronic kidney Disease complications by internal medicine residents: a national survey.
- Early detection of Acute kidney injury with neutrophil gelatinase-associated lipocalin.
- Comparison of the CKD Epidemiology Collaboration (CKD-EPI) andModification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD a...
- Sustainable community-based CKD screening methods employed by the National Kidney Foundation's Kidney Early Evaluation Program (KEEP).
- National Kidney Foundation's Kidney Early Evaluation Program (KEEP) annual data report 2010: executive summary.
- Shorter circular staple is height associated with lower anastomotic stricture rate in laparoscopic gastric bypass.
- Determinants of markedly increased B-type natriuretic peptide in patients with ST-segment elevation Myocardial infarction.
- Drug-eluting Coronary stents in patients with kidney disease.
- Influence of myocardial ischemia on outcomes in patients with systolic versus non-systolic Heart failure.
- Emerging practice patterns and outcomes of percutaneous Aortic balloon valvuloplasty in patients with severe Aortic stenosis.
- Effects of Intra-Arterial and Intravenous Iso-Osmolar Contrast Medium (Iodixanol) on the Risk of Contrast-Induced Acute Kidney Injury: A Meta-Analysis.
- Galectin-3: a novel blood test for the evaluation and management of patients with Heart failure.
- Clinical impact of renal dysfunction in Heart failure.
- Treatment of hypertriglyceridemia with fibric Acid derivatives: impact on lipid subfractions and translation into a reduction in cardiovascular events.
- Assessing appropriateness of Coronary intervention.
- The role of oxidative stress in the metabolic Syndrome.
- Gestational diabetes mellitus alone in the absence of subsequent diabetes is associated with microalbuminuria: results from the Kidney Early Evaluation Program (KEEP).
- Editorial: contrast-induced Acute kidney injury: shifting from elective to urgent coronary intervention.
- Effect of gastric bypass on vitamin D and secondary hyperparathyroidism.
- Increased Central Adiposity in Morbidly Obese Patients with Obstructive Sleep Apnea.
- Acute cardiac effects of marathon running.
- Myocardial ischemia in patients with diastolic dysfunction and Heart failure.
- Pre-procedural glucose levels and the risk for contrast-induced Acute kidney injury in patients undergoing coronary angiography.
- Behavioral predictors of weight regain after bariatric surgery.
- Racial differences in kidney function among individuals with obesity and metabolic Syndrome: results from the Kidney Early Evaluation Program (KEEP).
- Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).
- National Kidney Foundation's Kidney Early Evaluation Program (KEEP) annual data report 2009: executive summary.
- Cardiorenal interaction: appropriate treatment of cardiovascular risk factors to improve outcomes in chronic kidney Disease.
- Differential loss of fat and lean mass in the morbidly obese after bariatric surgery.
- Best of the ACC 2010 Scientific Session.
- Subarachnoid hemorrhage with neurocardiogenic stunning.
- An evidence-based algorithm for the use of B-type natriuretic testing in Acute coronary syndromes.
- Capturing the pathophysiology of Acute coronary syndromes with circulating biomarkers.
- Natriuretic peptides in the prognosis and management of Acute coronary syndromes.
- Differential diagnosis and overlap of Acute chest discomfort and dyspnea in the emergency department.
- Integration of the clinical laboratory in cardiovascular medicine.
- Kidney early evaluation program: a community-based screening approach to address disparities in chronic kidney Disease.
- Annual progression of Coronary calcification in trials of preventive therapies: a systematic review.
- Prostaglandin-based renal protection against contrast-induced Acute kidney injury.
- Serum cystatin C in the estimation of glomerular filtration on Chronic angiotensin-converting enzyme inhibitor therapy: an illustrative case report.
- Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with Acute dyspnea.
- Advantages of group treatment and structured exercise in promoting short-term weight loss and cardiovascular risk reduction in adults with central obesity.
- B-type natriuretic peptide and echocardiography in the surveillance of severe mitral regurgitation prior to Valve surgery.
- Darapladib and atherosclerotic plaque: should lipoprotein-associated phospholipase A2 be a therapeutic target?
- Cardiorespiratory fitness: an independent and additive marker of risk stratification and health outcomes.
- Impact of surgical and nonsurgical weight loss on diabetes resolution and cardiovascular risk reduction.
- Plasma parathyroid hormone level and prevalent cardiovascular Disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
- Hypertension in early-stage kidney Disease: an update from the Kidney Early Evaluation Program (KEEP).
- Executive summary: Kidney Early Evaluation Program (KEEP) 2008 annual data report.
- Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
- Cardiovascular implications of proteinuria: an indicator of chronic kidney Disease.
- Cardiorespiratory fitness and sedentary lifestyle in the morbidly obese.
- Serum cystatin C, renal filtration function, and left ventricular remodeling.
- Contrast-induced Acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology.
- Response to Cardiac Resynchronization Therapy Improves Renal Function. Importance of Forward and Backward Failure.
- Perception of indications for nephrology referral among internal medicine residents: a national online survey.
- Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein.
- Lipoproteins, inflammatory biomarkers, and cardiovascular imaging in the assessment of atherosclerotic Disease activity.
- Etiology and pathophysiology of new-onset Heart failure: evaluation by myocardial perfusion imaging.
- Improved noninvasive Coronary angiography in morbidly obese patients with dual-source computed tomography.
- Awareness and knowledge of clinical practice guidelines for CKD among internal medicine residents: a national online survey.
- Blood B-type natriuretic peptide and dialysis: present assessment and future analyses.
- Accelerated atherosclerotic calcification and Monckeberg's sclerosis: a continuum of advanced vascular pathology in chronic kidney Disease.
- Chronic kidney Disease as a cardiovascular risk state and considerations for the use of statins.
- Amplification of atherosclerotic calcification and Mönckeberg's sclerosis: a spectrum of the same Disease process.
- Influence of Chronic Renal Failure on Cardiac Structure.
- Impact of Enhanced External Counterpulsation on Heart Failure Rehospitalization in Patients With Ischemic Cardiomyopathy.
Schools
U Of Tx Southwestern Med Sch At Dallas
U Wash Affil Hosps
Baylor University
U Mich Mph
Procedures Preformed
- Cardiac Imaging
- Dobutamine Stress Echocardiography
- Echocardiography
- EKG (Electrocardiogram, ECG)
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
- Clinical Lipidology
- Internal Medicine
Accepted Insurances
Awards
- 11th International Vicenza Award in Critical Care Nephrology
- Fellow
- Simon Dack Award for Scholarly Excellence by the Journal of the American College of Cardiology
- Outstanding Poster Recognition
- Innovations in Health Care Award Finalist
- Listed in Guide to America’s Top Cardiologists
- Listed in Guide to America’s Top Physicians
- America’s Registry of Outstanding Professionals
- Young Investigator Award, President’s International Awards Ceremony
- Physician’s Recognition Award in Continuing Medical Education
- Chief Medical Resident's Best Teacher Award
- Alpha Omega Alpha, National Honor Medical Society
- Alpha Lambda Delta Freshman Honorary
- Fellow (FACC)
Education
-
William Beaumont Hospital -
University of Washington -
University of Texas Southwestern Medical School
Hospital
-
St. John Hospital and Medical Center
Drug Facts
| NPI NUMBER | 1386604700 | |
| NPPES Provider LastName | MCCULLOUGH | |
| NPPES Provider FirstName | PETER | |
| NPPES Provider ZIPCode | 752261339 | |
| NPPES Provider State | TX | |
| Specialty Description | Cardiology | |
| Total Claim Count | 575.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1386604700 |
| Last Name Of The Provider | MCCULLOUGH |
| First Name Of The Provider | PETER |
| View All |
Similar Doctors
|
Dr. Andrew Berggren, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Luna, MD |
|
|
Dr. Gregory A. Redish, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rafic F. Berbarie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan A. Matulevicius, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harold Lewis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cyril Varughese, DO |
|
|
Dr. Daniel D. Cheeran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Engleman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lu Q. Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abdallah El Sabbagh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hurst M. Hall III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard C. Wu, MD |
|
Dr. Christy B. Turer, MD
This Doctor is OpenDoctor Recommended.
|